Apollo Hospitals launches Strand’s clinical genomic tests

Apollo Hospitals has announced the launch of clinical genomic tests from the Strand Center for Genomics and Personalised Medicine across its hospital network which will help doctors diagnose disease precisely and identify optimal treatment.

These tests in oncology, cardiovascular, heritable eye diseases and rare genetic disorders shall be integrated into clinical practice by Apollo’s subsidiary, Sapien Biosciences in partnership with Strand Life Sciences, it said in a statement yesterday.

“These tests will help doctors diagnose disease more precisely, identify the optimal treatment and monitor disease and treatment course for better outcomes,” it said.

Genomic testing involves analysis of patient genomes – genes and sequences of DNA/RNA. The analysis helps create better prognostic tools for improved disease screening and prevention strategies. The patient benefits from optimised clinical care, personalisation of treatment and monitoring of outcomes, it was noted.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s